学会発表
研究業績













サイトマップ

■神戸朝日病院
--神戸市第二次救急病院--
〒653-0801
神戸市長田区房王寺町3-5-25
連絡先
電話: 078-612-5151(代)
FAX:078-612-5152
email:info@kobe-asahi-hp.com


 
HOMEへ戻る

 

▼原著論文 2006年以降 (1995年-2005年はこちら)
Case of adult genotype C HBV carrier after acute hepatitis B, losing HBsAg and acquiring HBsAb after IFN and lamivudine treatment.
Soo Ryang Kim, Susumu Imoto, Shuichi Fuki, Miyuki Taniguchi, Ke Ih Kim, Keiji Mita,  Kenji Ando, Taisuke Nakajima, Hyun Soo Hong, Katsumi Fukuda, Noriko Sasase, Masatoshi Kudo, Yoshitake Hayashi.
Hepatology Research 36: 149-152, 2006
Hepatocellular carcinoma metastasizing to the skull base involving multiple cranial nerves.
Soo Ryang Kim, Fumio Kanda, Hiroshi Kobessho, Koji Sugimoto, Toshiyuki Matsuoka, Masatoshi Kudo, Yoshitake Hayashi.
World Journal of Gastroenterology 12: 6727-6729, 2006
2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
Ke Ih Kim, Soo Ryang Kim, Noriko Sasase, Miyuki Taniguchi, Shinichi Harada,Kana Kinoshita, Sung Hi Kim, Yoko Akimoto, Mao Shikata, Noriyo Kimura, Satoko Izawa, Aya Ohtani, Keiko Nakao, Masayoshi Motojima, Mitsuko Kinoshita, Midori Hirai, Mariko Ohzu, Teruko Hirooka, Shizuka Nabeshima, Fumie Ishii, Kazuhiko Tanaka, Hak Hotta.
J Clin Pharm Ther 31:441-446,2006
Multistep hepatocarcinogenesis from dysplastic nodule to well-differentiated hepatocellular carcinoma in patient with alcohol-related liver cirrhosis.
Soo Ryang Kim, Hirotsugu Ikawa, Kenji Ando, Keiji Mita, Shuichi Fuki, Michiie Sakamoto, Yoshihiro Kanbara, Toshiyuki Matsuoka, Masatoshi Kudo, Yoshitake Hayashi.
World Journal of Gastroenterology 13:1271-1274, 2007
肝癌に対する生体移植医療をめぐる生命倫理学的考察.
金守良、井本勉、婦木秀一、安藤健治、猪川弘嗣、三田敬二、清水健嗣、寒原芳浩、林祥剛. 
兵庫県医師会医学雑誌 第49巻第2号:84-90,2007
気管支喘息として治療されていたが、血痰を契機に発見された有茎性気管支内腫瘍の1切除例
中嶋泰典、福岡和也、栗林康造他
兵庫県医師会医学雑誌 第49巻第2号:102-105,2007

Is long-term interferon monotherapy welcome news for older patients with chronic hepatitis C genotype 1?
Soo Ryang Kim.
Hepatology Research 2007;37487-489

Small hepatocellular carcinoma presenting with massive metastasis in the peritoneum, mimicking sarcomatous tumor.
Soo Ryang Kim, Hirotsugu Ikawa, Kenji Ando, Keiji Mita, Shuichi Fuki, Susumu Imoto, Kenji Shimizu, Yoshihiro Kanbara, Koji Sugimoto, Masahiko Fujii, Masatoshi Kudo, Toshiyuki Matsuoka, Yoshitake Hayashi.
Hepatology Research 2007;37:885-889
Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera.
Ahmed El-Shamy, Mikiko Sasayama, Motoko Nagano-Fujii, Noriko Sasase, Susumu Imoto, Soo Ryang Kim, Hak Hotta.
Microbiol Immunol 2007;51:471-482
アルコール性肝硬変にみられた多発性多血性結節の2症例. 
金守良、井本勉、工藤正俊.
アルコールと医学生物学Vol. 27.
Well to moderately differentiated HCC manifesting hyperattenuation on both CT during arteriography and arterial portography.
Soo Ryang Kim, Susumu Imoto, Hirotsugu Ikawa, Kenji Ando, Keiji Mita, Shuichi Fuki, Michiie Sakamoto, Yoshihiro Kanbara, Toshiyuki Matsuoka, Masatoshi Kudo, Yoshitake Hayashi.
World Journal of Gastroenterology 2007;13:5775-5778.
Blood cell and liver function changes by PEG-interferon-α2b plus ribavirin with polaprezinc therapy in patients with chronic hepatits C.
Ke Ih Kim, Soo Ryang Kim, Noriko Sasase, Yoko Akimoto, Mao Shikata, Aya Ohtani, Teruko Hirooka, Kazuhiko Tanaka.
Hepatol Int 2008;2:111-115
Superiority of CT arterioportal angiography of contrast-enhanced CT and MRI in the diagnosis of hepatocellular carcinoma in nodules smaller than 2cm.
Soo Ryang Kim, Kenji Ando, Keiji Mita, Shuichi Fuki, Hirotsugu Ikawa, Yoshihiro Kanbara, Susumu Imoto, Toshiyuki Matsuoka, Yoshitake Hayashi, Masatoshi Kudo.
Oncology 2007;72 (suppl 1):58-66
Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma.
Miyuki Taniguchi, Soo Ryang Kim, Susumu Imoto, Hirotsugu Ikawa, Kenji Ando, Keiji Mita, Shuichi Fuki, Noriko Sasase, Toshiyuki Matsuoka, Masatoshi Kudo, Yoshitake Hayashi.
World Journal of Gastroenterology 2008;14:1997-2002
1b型高ウイルス量高齢者C型慢性肝炎に対するPEG IFNα-2b/リバビリン治療(併用療法)の検討
金守良、井本勉、婦木秀一、金啓二、谷口美幸、長野基子、堀田博、勝二郁夫、寒原芳浩、前川陽子、工藤正俊、林祥剛. 
肝臓 2008年49巻145-152
Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy.
Ahmed El-Shamy, Motoko Nagano-Fujii, Noriko Sasase, Susumu Imoto, Soo Ryang Kim, Hak Hotta.
Hepatology 2008;48:38-47
Usefulness of a new immuno-radiometric assay of HCV core antigen to predict virological response during PEG-IFN/RBV combination therapy for chronic hepatitis with high viral loads of serum HCV RNA genotype 1b.
Noriko Sasase, Soo Ryang Kim, Ke Ih Kim, Miyuki Taniguchi, Susumu Imoto, Keiji Mita, Hak Hotta, Ikuo Shouji, Ahmed El-Shamy, Norifumi Kawada, Masatoshi Kudo, Yoshitake Hayashi.
Intervirology 2008;51 (suppl 1):70-75
Diagnostic accuracy of imaging for liver cirrhoisis compared to histologically proven liver cirrhosis.
Masatoshi Kudo, Rong Qin Zheng, Soo Ryang Kim, Yoshihiro Okabe, Yukio Osaki, Hiroko Iijima, Toshinao Itani, Hiroshi Kasugai, Masayuki Kanematsu, Katsuyoshi Ito, Norio Usuki, Kazuhide Shimamatsu, Masayoshi Kage, Masamichi Kojiro.
Intervirology 2008;51 (suppl 1):17-26
慢性肝疾患を背景とする直径2cm以下結節に対する取扱いについての提言―血管造影下CT、生検所見を踏まえて―
金守良
消化器科 2008年第46巻673-679
Epidemiology of hepatocellular carcinoma in Japan and Korea.
Soo Ryang Kim, Masatoshi Kudo, Okio Hino, Kwang Hyub Han, Yung Hwa Chung, Hyo Suk Lee, the organizing committee of Japan-Korea Liver Symposium.
Oncology 2008;75(suppl 1)13-16
Two cases of non-alcoholic steato-hepatitis developing from simple fatty liver.
Soo Ryang Kim, Susumu Imoto, Hirotsugu Ikawa, Kenji Ando, Keiji Mita, Shuichi Fuki, Miyuki Taniguchi, Noriko Sasase, Toshiyuki Matsuoka, Masatoshi Kudo, Yoshitake Hayashi.
J Gastrointestin and Liver Dis 2009;18:491-495
Focal nodular hyperplasia-like lesion with venous washout in alcoholic liver cirrhosis.
Soo Ryang Kim, Susumu Imoto, Hirotsugu Ikawa, Kenji Ando, Keiji Mita, Kenji Shimizu, Miyuki Taniguchi, Noriko Sasase, Toshiyuki Matsuoka, Masatoshi Kudo, Norifumi Kawada, Yoshitake Hayahshi.
Internal Med 2008;47:1899-1903
Scirrhous hepatocellular carcinoma displaying atypical findings on imaging studies.
Soo Ryang Kim, Susumu Imoto, Taisuke Nakajima, Kenji Ando, Keiji Mita, Katsumi Fukuda, Ryo Nishikawa, Yuichiro Koma, Toshiyuki Matsuoka, Masatoshi Kudo, Yoshitake Hayashi
World Journal of Gastroenterology 2009 ;15:2296-2299
Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum HCV RNA, genotype 1b, discontinued on attaining sustained virological response in week 16 after onset of acute pancreatitis
Soo Ryang Kim, Susumu Imoto, Keiji Mita, Miyuki Taniguchi, Noriko Sasase, Akira Muramatsu, Masatoshi Kudo, Satoshi Kitai, Ahmed El-Shamy, Hak Hotta, Yoshitake Hayashi
Digestion 2009;79:36-39
Epidemiology of hepatitis E in Northeastern China, South Korea and Japan.
Miyuki Taniguchi, Soo Ryang Kim, Shunji Mishiro, Kazuaki Takahashi, Myung Hee Shin, Haesun Yun, Man Suk Park, Zhong Min Li, Mi Kyung Kim, Jinnv Fang , Yoshitake Hayashi
Journal of Infection 2009;58:232-237
ソナゾイド造影超音波の有用性-病理所見を踏まえて
金守良,井本勉,三田敬二,安藤健治,福田勝美,日数谷剛,野崎ゆきえ,昌山光雄
INNERVISION 2009; 3:98-100
Well-differentiated hepatocellular carcinoma smaller than 15mm in diameter totally eradicated with percutaneous ethanol injection instead of radiofrequency ablation
Soo Ryang Kim, Susumu Imoto, Taisuke Nakajima, Kenji Ando, Keiji Mita, Miyuki Taniguchi, Noriko Sasase, Toshiyuki Matsuoka, Masatoshi Kudo, Yoshitake Hayashi.
Hepatology International 2009;3:411-415
1b型高ウイルスC型慢性肝炎のPEG-IFN+リバビリン併用療法無効例に対する二重濾過血漿交換療法+IFN-β 4週間連続投与の試み―早期ウイルスdynamicsを中心に―. 
金守良、井本勉、他. 
肝臓 50巻.470-472:2009年
Acute pancreatitis associated with pegylated interferon and ribavirin treatment of chronic hepatitis C, genotype 1b with high viral load.
Kenji Ando, Soo Ryang Kim, Susumu Imoto, Taisuke Nakajima, Keiji Mita,
Katsumi Fukuda, Miyuki Taniguchi, Noriko Sasase, Akira Muramatsu,
Toshiyuki Matsuoka, Masatoshi Kudo, Yoshitake Hayashi
Case Reports in Gastroenterology,2009;3:372-376
Double filtration plasmapheresis plus IFN for HCV-1b patients with non-sustained virological response to previous therapy : early viral dynamics.
Soo Ryang Kim, Susumu Imoto, Keiji Mita, Miyuki Taniguchi, Ke Ih Kim, Ikuo Shouji, Motoko Nagano, Hak Hotta, Tomoyuki Nagai, Yoshiaki Nagata, Masatoshi Kudo, Yoshitake Hayashi.
Intervirology 2010;53:44-48
The relation between effect of outcome and early viral dynamics with viral mutation in PEG-IFN/RBV combination therapy for chronic hepatitis with high viral loads of serum HCV RNA genotype 1b.
Noriko Sasase, Soo Ryang Kim, Ke Ih Kim, Miyuki Taniguchi, Susumu Imoto, Keiji Mita, Masatoshi Kudo, Yoshitake Hayashi, Ikuo Shouji, Ahmed El-Shamy.
Intervirology Intervirology 2010;53-49-54
Comparison of prevalence of metabolic syndrome between Korean emigrants and host country residents in Japan and China-the Korean emigrant study.
Myung-Hee Shin, Mi Kyung Kim, Zhong Min Li, Hyun-Kyung Oh, Soo Ryang Kim, Miyuki Taniguchi, Jinnv Fang.
Epidemiology and Health 2010;32:e2010005.
Autoimmune thrombocytopenic purpura during pegylated interferon α treatment for chronic hepatitis C.
Soo Ryang Kim, Susumu Imoto, Masatoshi Kudo, Taisuke Nakajima, Kenji Ando, Keiji Mita, Katsumi Fukuda, Hyun Soo Hong, Yeong Ho Lee, Keiichi Nakashima, Ikuo Shoji, Motoko Nagano-Fujii, Hak Hotta, Yoshitake Hayashi.
Internal Medicine [in press]
Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm.
Keiji Mita, Soo Ryang Kim, Masatoshi Kudo, Susumu Imoto, Taisuke Nakajima, Kenji Ando, Katsumi Fukuda, Toshiyuki Matsuoka, Yoko Maekawa, Yoshitake Hayashi.
World Journal of Gastroenterology [in press]
Peginterferon alpha-2a versus alpha-2b in chronic hepatitis C.
Soo Ryang Kim.
Hepatitis Monthly [in press]
DFPPとIFNの併用療法−BIRD療法を中心に−.
金守良、井本勉、安藤健治、中嶋泰典、福田勝美、中島圭一、李英浩、前川陽子、金啓二、笹瀬典子、大谷綾、木村訓世、山本香織、笹谷佳菜子、小西恵里香、杉本佳世、藤野咲子.
肝胆膵 [in press]


▲このページのTOPへ

©2001-2010 KOBE ASAHI HOSPITAL. All Rights Reserved.